Stellar Pharmaceuticals Inc. Reports Third Quarter Financial Results

Stellar Pharmaceuticals Inc., (TSX VENTURE:SLX)(OTCBB:SLXCF);, a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the third quarter ended September 30, 2005. All amounts in this press release are in Canadian dollars, and are the result of the use of U.S. GAAP.

Back to news